{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T23:09:14Z","timestamp":1783206554014,"version":"3.54.6"},"reference-count":31,"publisher":"CSIRO Publishing","issue":"4","license":[{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"vor","delay-in-days":1879,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,7]]},"abstract":"<jats:p>Understanding patient-perceived outcomes is crucial for assessing the effectiveness and acceptability of hepatitis C virus (HCV) treatment. This study aimed to explore patient-perceived outcomes of receiving direct-acting antivirals (DAAs). This study was a part of a mixed-methods case study of the Prince Charles Hospital program for improving access to HCV treatment in community settings. Data were collected using semi-structured interviews with nine patients who were in different stages of their treatment for HCV. The participants were recruited using purposive sampling. All interviews were audio-recorded, transcribed verbatim and analysed using thematic analysis. Patients emphasised \u2018having more energy\u2019 when reporting improvements in their physical health following treatment. They also reported a newly developed sense of freedom and hope. Improved physical and mental health empowered them to start a healthy lifestyle and to practise self-protection from the risk of re-infection. Patients highlighted their desire to help other patients to receive treatment, which was connected to their experience of the services that they received and their perceived health outcomes. Patients expect and experience various outcomes that are related to the physical, psychological and social aspects of living with, and being cured of HCV. Emphasis on the short-term outcomes of receiving HCV treatment may improve HCV treatment uptake and adherence rates.<\/jats:p>","DOI":"10.1071\/py20013","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T22:13:10Z","timestamp":1593036790000},"page":"319-324","source":"Crossref","is-referenced-by-count":10,"title":["\u2018I\u2019m over the moon!\u2019: patient-perceived outcomes of hepatitis C treatment"],"prefix":"10.1071","volume":"26","author":[{"given":"Davoud","family":"Pourmarzi","sequence":"first","affiliation":[{"name":"ASchool of Public Health and Social Work, Faculty of Health, Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology, Brisbane, Qld 4059, Australia."},{"name":"BNational Centre for Epidemiology and Population Health, Research School of Population Health, College of Health and Medicine, The Australian National University, Canberra, ACT 2601, Australia."},{"name":"ECorresponding author. Email: davoud.pourmarzi@anu.edu.au"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Smirnov","sequence":"additional","affiliation":[{"name":"BNational Centre for Epidemiology and Population Health, Research School of Population Health, College of Health and Medicine, The Australian National University, Canberra, ACT 2601, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hall","sequence":"additional","affiliation":[{"name":"CSchool of Public Health, Faculty of Medicine, The University of Queensland, Brisbane, Qld 4006, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"FitzGerald","sequence":"additional","affiliation":[{"name":"ASchool of Public Health and Social Work, Faculty of Health, Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology, Brisbane, Qld 4059, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Rahman","sequence":"additional","affiliation":[{"name":"DDepartment of Gastroenterology and Hepatology, The Prince Charles Hospital, Brisbane, Qld 4032, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"key":"2025102822261333500_R1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.drugalcdep.2015.06.007","article-title":"\u201cHepatitis C treatment turned me around:\u201d psychological and behavioral transformation related to hepatitis C treatment.","volume":"153","author":"Batchelder","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"2025102822261333500_R2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology.","volume":"3","author":"Braun","year":"2006","journal-title":"Qualitative Research in Psychology"},{"issue":"4","key":"2025102822261333500_R3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4103\/2229-3485.86879","article-title":"Patient-reported outcomes: a new era in clinical research.","volume":"2","author":"Deshpande","year":"2011","journal-title":"Perspectives in Clinical Research"},{"key":"2025102822261333500_R4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3268650","article-title":"Living with hepatitis C virus: a systematic review and narrative synthesis of qualitative literature.","volume":"2017","author":"Dowsett","year":"2017","journal-title":"Canadian Journal of Gastroenterology & Hepatology"},{"issue":"6","key":"2025102822261333500_R5","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/phn.12665","article-title":"The role of stigma and trauma in hepatitis C virus treatment in veterans: applying the common-sense model.","volume":"36","author":"Garvey","year":"2019","journal-title":"Public Health Nursing (Boston, Mass.)"},{"issue":"3","key":"2025102822261333500_R6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cld.2017.03.011","article-title":"Patient-reported outcomes and fatigue in patients with chronic hepatitis C infection.","volume":"21","author":"Golabi","year":"2017","journal-title":"Clinics in Liver Disease"},{"issue":"2","key":"2025102822261333500_R7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/jvh.13020","article-title":"Improving hepatitis C direct-acting antiviral access and uptake: a role for patient-reported outcomes and lived experience.","volume":"26","author":"Goutzamanis","year":"2019","journal-title":"Journal of Viral Hepatitis"},{"issue":"4","key":"2025102822261333500_R8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S2468-1253(16)30075-9","article-title":"Hepatitis C treatment as prevention: evidence, feasibility, and challenges.","volume":"1","author":"Hajarizadeh","year":"2016","journal-title":"The Lancet. Gastroenterology & Hepatology"},{"key":"2025102822261333500_R9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.drugpo.2017.03.015","article-title":"Managing expense and expectation in a treatment revolution: problematizing prioritisation through an exploration of hepatitis C treatment \u2018benefit\u2019.","volume":"47","author":"Harris","year":"2017","journal-title":"The International Journal on Drug Policy"},{"key":"2025102822261333500_R10","unstructured":"Hepatitis C Virus Infection Consensus Statement Working Group (2018) Australian recommendations for the management of hepatitis C virus infection: a consensus statement. Gastroenterological Society of Australia: Melbourne, Vic., Australia) Available at https:\/\/www.asid.net.au\/documents\/item\/1208 [Verified 25 May 2020]"},{"issue":"4","key":"2025102822261333500_R11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.gtc.2015.07.003","article-title":"Natural history of hepatitis C.","volume":"44","author":"Lingala","year":"2015","journal-title":"Gastroenterology Clinics of North America"},{"issue":"1","key":"2025102822261333500_R12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12954-018-0248-4","article-title":"Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia.","volume":"15","author":"Madden","year":"2018","journal-title":"Harm Reduction Journal"},{"issue":"11","key":"2025102822261333500_R13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207226","article-title":"Beyond interferon side effects: what residual barriers exist to DAA hepatitis C treatment for people who inject drugs?","volume":"13","author":"Madden","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"2025102822261333500_R14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","article-title":"Purposeful sampling for qualitative data collection and analysis in mixed method implementation research.","volume":"42","author":"Palinkas","year":"2015","journal-title":"Administration and Policy in Mental Health"},{"issue":"3","key":"2025102822261333500_R15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1071\/AH18220","article-title":"Framework for community-based models for treating hepatitis C virus.","volume":"44","author":"Pourmarzi","year":"2019","journal-title":"Australian Health Review"},{"issue":"2","key":"2025102822261333500_R16","doi-asserted-by":"publisher","first-page":"e1247","DOI":"10.1002\/hpm.2770","article-title":"Elements of community-based models for treating hepatitis C virus in supporting HCV elimination in Australia: a Delphi study.","volume":"34","author":"Pourmarzi","year":"2019","journal-title":"The International Journal of Health Planning and Management"},{"key":"2025102822261333500_R17","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1186\/s12889-019-7604-5","article-title":"Outcomes of a tertiary-based innovative approach to engage primary care providers in provision of hepatitis C treatment in community settings.","volume":"19","author":"Pourmarzi","year":"2019","journal-title":"BMC Public Health"},{"issue":"4","key":"2025102822261333500_R18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/jvh.13045","article-title":"Clinical effectiveness, cost effectiveness and acceptability of community-based treatment of hepatitis C virus infection: a mixed method systematic review.","volume":"26","author":"Pourmarzi","year":"2019","journal-title":"Journal of Viral Hepatitis"},{"issue":"5","key":"2025102822261333500_R19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/jvh.13259","article-title":"Enablers and barriers for the provision of community-based HCV treatment: a case study of a real-world practice.","volume":"27","author":"Pourmarzi","year":"2020","journal-title":"Journal of Viral Hepatitis"},{"key":"2025102822261333500_R20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41124-018-0036-5","article-title":"Achieving a hepatitis C cure: a qualitative exploration of the experiences and meanings of achieving a hepatitis C cure using the direct acting antivirals in Australia.","volume":"3","author":"Richmond","year":"2018","journal-title":"Hepatology, Medicine and Policy"},{"key":"2025102822261333500_R21"},{"issue":"4","key":"2025102822261333500_R22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/jurban\/jth153","article-title":"Co-occurring hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.","volume":"81","author":"Sylvestre","year":"2004","journal-title":"Journal of Urban Health"},{"issue":"8","key":"2025102822261333500_R23","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/jvh.12183","article-title":"Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study.","volume":"21","author":"Treloar","year":"2014","journal-title":"Journal of Viral Hepatitis"},{"issue":"6","key":"2025102822261333500_R24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1071\/PY18024","article-title":"Delivering the hepatitis C cure to Aboriginal people: documenting the perspectives of one Aboriginal Health Service.","volume":"24","author":"Wallace","year":"2018","journal-title":"Australian Journal of Primary Health"},{"key":"2025102822261333500_R25"},{"key":"2025102822261333500_R26"},{"issue":"2","key":"2025102822261333500_R27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.idh.2018.10.006","article-title":"\u201cI\u2019m obviously not dying so it\u2019s not something I need to sort out today\u201d: considering hepatitis C treatment in the era of direct acting antivirals.","volume":"24","author":"Wright","year":"2019","journal-title":"Infection, Disease & Health"},{"issue":"10","key":"2025102822261333500_R28","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1377\/hlthaff.2010.0660","article-title":"Adding the patient perspective to comparative effectiveness research.","volume":"29","author":"Wu","year":"2010","journal-title":"Health Affairs"},{"issue":"6","key":"2025102822261333500_R29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/apt.13090","article-title":"Systematic review: patient-reported outcomes in chronic hepatitis C\u2013the impact of liver disease and new treatment regimens.","volume":"41","author":"Younossi","year":"2015","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"2025102822261333500_R30","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jval.2016.02.005","article-title":"Performance and Validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in clinical trials of patients with chronic hepatitis C.","volume":"19","author":"Younossi","year":"2016","journal-title":"Value in Health"},{"issue":"5","key":"2025102822261333500_R31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/MCG.0000000000001179","article-title":"A comprehensive review of patient-reported outcomes in patients with chronic liver diseases.","volume":"53","author":"Younossi","year":"2019","journal-title":"Journal of Clinical Gastroenterology"}],"container-title":["Australian Journal of Primary Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/py\/article-pdf\/26\/4\/319\/753743\/py20013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/py\/article-pdf\/26\/4\/319\/753743\/py20013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:26:19Z","timestamp":1761704779000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/py\/article\/26\/4\/319\/92514\/I-m-over-the-moon-patient-perceived-outcomes-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8,7]]}},"URL":"https:\/\/doi.org\/10.1071\/py20013","relation":{},"ISSN":["1448-7527","1836-7399"],"issn-type":[{"value":"1448-7527","type":"print"},{"value":"1836-7399","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,25]]}}}